Find information on thousands of medical conditions and prescription drugs.

Cystinosis

Cystinosis is a hereditary dysfunction of the renal tubules characterized by the presence of carbohydrates and amino acids in the urine, excessive urination, and low blood levels of potassium ions and phosphates. more...

Home
Diseases
A
B
C
Angioedema
C syndrome
Cacophobia
Café au lait spot
Calcinosis cutis
Calculi
Campylobacter
Canavan leukodystrophy
Cancer
Candidiasis
Canga's bead symptom
Canine distemper
Carcinoid syndrome
Carcinoma, squamous cell
Carcinophobia
Cardiac arrest
Cardiofaciocutaneous...
Cardiomyopathy
Cardiophobia
Cardiospasm
Carnitine transporter...
Carnitine-acylcarnitine...
Caroli disease
Carotenemia
Carpal tunnel syndrome
Carpenter syndrome
Cartilage-hair hypoplasia
Castleman's disease
Cat-scratch disease
CATCH 22 syndrome
Causalgia
Cayler syndrome
CCHS
CDG syndrome
CDG syndrome type 1A
Celiac sprue
Cenani Lenz syndactylism
Ceramidase deficiency
Cerebellar ataxia
Cerebellar hypoplasia
Cerebral amyloid angiopathy
Cerebral aneurysm
Cerebral cavernous...
Cerebral gigantism
Cerebral palsy
Cerebral thrombosis
Ceroid lipofuscinois,...
Cervical cancer
Chagas disease
Chalazion
Chancroid
Charcot disease
Charcot-Marie-Tooth disease
CHARGE Association
Chediak-Higashi syndrome
Chemodectoma
Cherubism
Chickenpox
Chikungunya
Childhood disintegrative...
Chionophobia
Chlamydia
Chlamydia trachomatis
Cholangiocarcinoma
Cholecystitis
Cholelithiasis
Cholera
Cholestasis
Cholesterol pneumonia
Chondrocalcinosis
Chondrodystrophy
Chondromalacia
Chondrosarcoma
Chorea (disease)
Chorea acanthocytosis
Choriocarcinoma
Chorioretinitis
Choroid plexus cyst
Christmas disease
Chromhidrosis
Chromophobia
Chromosome 15q, partial...
Chromosome 15q, trisomy
Chromosome 22,...
Chronic fatigue immune...
Chronic fatigue syndrome
Chronic granulomatous...
Chronic lymphocytic leukemia
Chronic myelogenous leukemia
Chronic obstructive...
Chronic renal failure
Churg-Strauss syndrome
Ciguatera fish poisoning
Cinchonism
Citrullinemia
Cleft lip
Cleft palate
Climacophobia
Clinophobia
Cloacal exstrophy
Clubfoot
Cluster headache
Coccidioidomycosis
Cockayne's syndrome
Coffin-Lowry syndrome
Colitis
Color blindness
Colorado tick fever
Combined hyperlipidemia,...
Common cold
Common variable...
Compartment syndrome
Conductive hearing loss
Condyloma
Condyloma acuminatum
Cone dystrophy
Congenital adrenal...
Congenital afibrinogenemia
Congenital diaphragmatic...
Congenital erythropoietic...
Congenital facial diplegia
Congenital hypothyroidism
Congenital ichthyosis
Congenital syphilis
Congenital toxoplasmosis
Congestive heart disease
Conjunctivitis
Conn's syndrome
Constitutional growth delay
Conversion disorder
Coprophobia
Coproporhyria
Cor pulmonale
Cor triatriatum
Cornelia de Lange syndrome
Coronary heart disease
Cortical dysplasia
Corticobasal degeneration
Costello syndrome
Costochondritis
Cowpox
Craniodiaphyseal dysplasia
Craniofacial dysostosis
Craniostenosis
Craniosynostosis
CREST syndrome
Cretinism
Creutzfeldt-Jakob disease
Cri du chat
Cri du chat
Crohn's disease
Croup
Crouzon syndrome
Crouzonodermoskeletal...
Crow-Fukase syndrome
Cryoglobulinemia
Cryophobia
Cryptococcosis
Crystallophobia
Cushing's syndrome
Cutaneous larva migrans
Cutis verticis gyrata
Cyclic neutropenia
Cyclic vomiting syndrome
Cystic fibrosis
Cystinosis
Cystinuria
Cytomegalovirus
Dilated cardiomyopathy
Hypertrophic cardiomyopathy
Restrictive cardiomyopathy
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Cause

It is caused by abnormal transport of the amino acid cystine from lysosomes of all tissues, resulting in a massive intra-lysosomal cystine accumulation. Via an as yet unknown mechanism, lysosomal cystine appears to amplify apoptosis such that cells die inappropriately, leading to loss of renal epithelial cells, accounting for the renal Fanconi syndrome, and simlar loss in other tissues can account for the short stature, retinopathy, and other features of the disease.

Symptoms

Symptoms include Fanconi Syndrome, photophobia, stunted growth and rickets. It is currently being researched at UC San Diego, Tulane University School of Medicine, and at the National Institutes of Health in Bethesda, Maryland.

Genetics

The cause of cystinosis is due to a mutation in the gene CTNS which codes for cystinosin, the lysosomal cystine transporter. Symptoms are seen about 6-18 months of age with profound polyuria ( excessive urination), followed by poor growth, photophobia, and ultimately kidney failure by age 10 years in the nephropathic form. It is importanat for the child to see a biochemical geneticist and pediatric nephrologist to begin cyteamine as early as possible. Cysteamine decreases the amount of cystine stored in lysosomes and correlates with conservation of renal function and improved growth. Cysteamine eyedrops remove the cystine crystals in the cornea that cause photophobia and may impair vision after age 20 years. All forms of cystinosis ( nephropathic, juvenile and ocular) are inherited as autosomal recessive traits, which means that there is a 25% recurrence risk to any couple who have had an affected child. The disease " breeds true" such that parents of a child with the juvenile variety of cystinosis will not have another child with the nephropathic form, etc.

Types

  • OMIM 219800 - Infantile nephropathic
  • OMIM 219900 - Adolescent nephropathic
  • OMIM 219750 - Adult nonnephropathic

Read more at Wikipedia.org


[List your site here Free!]


Infantile Cystinosis
From Archives of Pathology & Laboratory Medicine, 1/1/05 by Rakheja, Dinesh

A 10-year-old boy with a diagnosis of infantile cystinosis and progressive renal failure underwent bilateral nephrectomy in preparation for renal transplantation. The native right kidney weighed 42.1 g (expected weight, 82 g), and the native left kidney weighed 36.1 g (expected weight, 83 g). Multiple sections from both the kidneys were fixed in 10% neutral buffered formalin and processed routinely for light microscopy. The sections showed global sclerosis of 30% to 40% of the glomeruli (Figure 1, hematoxylin-eosin, original magnification X40). The remaining glomeruli showed varying degrees of segmental sclerosis and capillary basement membrane thickening. Occasional giant cell transformation of the glomerular visceral epithelial cells was seen. We did not identify the "dark" cells, which are considered to be unique to cystinotic kidneys. The tubules showed moderate-to-severe atrophy with scattered dilated tubules. Some tubular lumens contained hyaline casts. A few tubular epithelial cells showed protein resorption droplets in their cytoplasm. Interstitial fibrosis and multiple foci of chronic inflammation predominantly composed of lymphocytes were seen. Occasional tubular and interstitial calcification was seen. With the help of a polarizer attachment to the light microscope, birefringent rectangular to polygonal crystals of cystine were seen in the tubular and interstitial cells (Figure 2, hematoxylin-eosin, original magnification ×100).

Cystinosis is an inherited, autosomal recessive disorder of lysosomal storage caused by a defective lysosomal integral membrane protein, cystinosin, which transports cystine (a disulfide of the amino acid cysteine) out of the lysosomes. A defect in cystinosin leads to abnormal lysosomal accumulation of soluble and crystalline cystine in various organs of the body. Cystinosin is encoded by the gene CTNS, which has been mapped to chromosome 17p13. The most common mutation that leads to cystinosis is a 57-kb deletion upstream of and including exon 10. This mutation is found in more than three quarters of the patients of European descent. A genotype-phenotype correlation occurs, with the more severe mutations leading to the nephropathic infantile form of the disease (OMIM 219800). Less severe mutations lead to the nephropathic late-onset (OMIM 219900) and the nonnephropathic ocular (OMIM 219750) forms of cystinosis. The infantile form of the disease occurs with an incidence of 1 in 100000 to 200000 live births and a carrier frequency of 1 in 200 in the North American population. The incidence is higher in parts of Western Europe, including France, the United Kingdom, and Germany. The untreated infantile form is the most common inherited form of renal Fanconi syndrome, but it also causes glomerular disease, leading to progressive renal failure that requires dialysis or renal transplantation by the age of 10 years. Although normal at birth, these children fail to grow and gain weight appropriately and develop electrolyte imbalances, renal tubular acidosis, hypophosphatemic rickets, photophobia, hypothyroidism, and heat intolerance due to diminished sweat production. The transplanted donor kidney does not develop abnormal accumulations of cystine, but the patients continue to store large amounts of cystine in other organs, leading to the late-onset manifestations of retinal blindness, corneal erosions, type 1 diabetes mellitus, pancreatic insufficiency, primary testicular failure, and neurologic symptoms. Skeletal myopathy leads to weakness, hypophonia, dysphagia, and diminished pulmonary function. The patients with late-onset variants of nephropathic cystinosis have slower progression of their renal and extrarenal disease and do not manifest growth retardation. The disease in the nonnephropathic ocular form of cystinosis is limited to the eyes. Further studies are under way to explain the exact mechanisms of organ damage in cystinosis.

The diagnosis of cystinosis does not require tissue biopsies and histologic evaluation but can be made by slitlamp examination of the cornea, revealing crystalline keratopathy. However, cystine crystals in the cornea are not usually detectable in the first year. Patchy deposition is seen at 12 to 24 months, and the untreated cornea is packed with crystals by 3 to 4 years of age. The diagnosis can be confirmed by measuring cystine content of peripheral white blood cells. Besides symptomatic therapy, the key to an improved quality of life and prolonged survival in patients with infantile cystinosis lies in early diagnosis and initiation of treatment with cysteamine bitartrate before the age of 2 years. Cysteamine enters the lysosomes by a specific transporter and converts cystine to cysteine and cysteine-cysteamine mixed disulfide. Cysteine and cysteine-cysteamine then exit the lysosome by their respective carrier proteins. Oral cysteamine therapy reduces the accumulation of lysosomal cystine in all body cells except for the epithelial cells of the avascular cornea. Topical cysteamine eyedrops clear cystine accumulations in the cornea.1,2

References

1. Gahl WA, Thoene JG, Schneider JA. Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic & Molecular Bases of Inherited Disease. 8th ed. New York, NY: McCrawHill; 2001:5085-5108.

2. Kalatzis V, Antignac C. New aspects of the pathogenesis of cystinosis. Pediatr Nephrol. 2003;18:207-215.

Dinesh Rakheja, MD; Dennis C. Wooten, MD, PhD; Ana M. Cornez, MD, PhD

Accepted for publication August 20, 2004.

From the Departments of Pathology, Children's Medical Center of Dallas (Drs Rakheja and Comez), and University of Texas Southwestern Medical Center (Drs Rakheja, Wooten, and Gomez), Dallas, Tex.

The authors have no relevant financial interest in the products or companies described in this article.

Reprints: Dinesh Rakheja, MD, Department of Pathology, Mail Code 9073, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 (e-mail: dinesh.rakheja@ utsouthwestern.edu).

Copyright College of American Pathologists Jan 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Cystinosis
Home Contact Resources Exchange Links ebay